Immunological considerations and challenges for regenerative cellular therapies

Area of Science:

• Regenerative Medicine
• Immunology
• Cell Therapy

Background:

• Pluripotent stem cells offer therapeutic potential for tissue repair.
• Clinical translation of stem cell therapies is hindered by immune rejection.
• Host immune responses, both innate and adaptive, trigger allogeneic graft rejection.

Purpose of the Study:

• To describe the role of host immune responses in allogeneic graft rejection.
• To discuss how cellular therapy influences the immune response.
• To review methods for examining cell therapy immunogenicity and strategies to overcome rejection.

Main Methods:

• Review of host innate and adaptive immune responses.
• Analysis of factors determining immune response to cellular therapy.
• Examination of in vitro and in vivo experimental approaches.
• Review of strategies to ameliorate immune rejection.

Main Results:

• Host immune responses are key triggers of allogeneic graft rejection.
• The nature of the cellular therapy dictates the immune response.
• Various experimental approaches exist to assess cell therapy immunogenicity.
• Strategies to mitigate immune rejection are available.

Conclusions:

• Comprehensive investigation of cell therapy immunogenicity is essential for clinical safety and efficacy.
• Multidisciplinary platforms are needed to address immune rejection challenges.
• Overcoming immune barriers is critical for advancing regenerative medicine.